Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apexbio Technology LLC Z-LLNLE-CHO-5MG
SDP

Catalog No. 5000568915
Encompass_Preferred

Z-LLNle-CHO (CAS No 133407-83-7) is a synthetic peptide aldehyde used in biomedical research particularly as a protease inhibitor This compound is derived from a combination of peptide chemistry and organic synthesis targeting proteolytic enzymes such as calpains Its mechanism of action involves binding to the active site of these enzymes inhibiting their proteolytic activity which is crucial in various cellular processes Z-LLNle-CHO exhibits in vitro activity in the nanomolar to low micromolar range making it effective in studies where precise inhibition of protease activity is required Typical applications include experiments with cultured cell models assessments in animal studies and high-throughput drug screening for potential therapeutic agents targeting protease-related pathways Experimental concentrations typically depend on the specific research design encompassing a range of conditions tailored to the study objectives

Catalog No. 50-005-68915 Supplier Apexbio Technology LLC Supplier No. BA32705
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Z-LLNle-CHO (CAS No 133407-83-7) is a synthetic peptide aldehyde used in biomedical research particularly as a protease inhibitor This compound is derived from a combination of peptide chemistry and organic synthesis targeting proteolytic enzymes such as calpains Its mechanism of action involves binding to the active site of these enzymes inhibiting their proteolytic activity which is crucial in various cellular processes Z-LLNle-CHO exhibits in vitro activity in the nanomolar to low micromolar range making it effective in studies where precise inhibition of protease activity is required Typical applications include experiments with cultured cell models assessments in animal studies and high-throughput drug screening for potential therapeutic agents targeting protease-related pathways Experimental concentrations typically depend on the specific research design encompassing a range of conditions tailored to the study objectives

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.